Elanco, NYSE and Animal Health

Elanco Animal Health Incorporated (NYSE:ELAN) reported fourth-quarter revenue of $1.02 billion, a decrease of 1% on a ...
Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with South Dakota-based ...
Stifel analyst Jonathan Block lowered the firm’s price target on Elanco (ELAN) to $15 from $16 and keeps a Buy rating on the shares. While the ...
Elanco Animal Health (NYSE:ELAN) stock falls as the company reports mixed Q4 2024 results, and sets 2025 outlook below consensus due to forex headwinds. Read more here.
Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the Company will participate in the following investor ...
Elanco (ELAN) has entered into an agreement with South Dakota-based Medgene to leverage the company’s innovative vaccine platform technology.
Elanco Animal Health announced the launch and availability of products to promote skin health, gastrointestinal health, hip ...